Skip to main content

Medtronic plc International revenue

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

International revenue at Medtronic plc came to $4.9B for the quarter to 31 Jul 2026, up 11.4% from a year earlier.

As Medtronic plc reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Sep 2026.

By quarter

$3.8BOct 2023$4.0BJan 2024$4.2BApr 2024$3.8BJul 2024$4.1BOct 2024$4.1BJan 2025$4.4BApr 2025$4.4BJul 2025$4.4BOct 2025$4.5BJan 2026$4.9BApr 2026$4.9BJul 2026
Medtronic plc International revenue, every reported period
Period endingInternational revenueChange on a yearFiled
31 Jul 2026$4.9Bup 11.4%3 Sep 2026
24 Apr 2026$4.9Bup 12.8%18 Jun 2026
23 Jan 2026$4.5Bup 11.6%24 Feb 2026
24 Oct 2025$4.4Bup 8.4%25 Nov 2025
25 Jul 2025$4.4Bup 13.6%26 Aug 2025
25 Apr 2025$4.4Bup 3.1%20 Jun 2025
24 Jan 2025$4.1Bup 2.2%25 Feb 2025
25 Oct 2024$4.1Bup 7.6%26 Nov 2024
26 Jul 2024$3.8Bup 1.5%27 Aug 2024
26 Apr 2024$4.2B—20 Jun 2024
26 Jan 2024$4.0B—27 Feb 2024
27 Oct 2023$3.8B—30 Nov 2023
28 Jul 2023$3.8B—31 Aug 2023

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Medtronic plc: Electrophysiology Therapies revenue · Surgical & Endoscopy revenue · Cranial & Spinal Technologies revenue · Structural Heart & Aortic revenue · Specialty Therapies revenue · Coronary & Peripheral Vascular revenue · Acute Care & Monitoring revenue · Neuromodulation revenue · Reportable segment net sales · Cardiovascular revenue · Neuroscience revenue · Medical Surgical revenue · Diabetes revenue · United States revenue · Rest of world revenue · Ireland revenue · financial statements

Every KPI and segment of MDT, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.